Applied Biosystems and Chromsystems Team Up to Simplify Mass Spectrometry for Clinical Research
News Jul 22, 2009
Applied Biosystems and Chromsystems Instruments & Chemicals GmbH announced joint solutions that provide complete, integrated workflows to simplify mass spectrometry technology for a variety of clinical research applications, such as therapeutic drug monitoring.
These solutions are expected to accelerate the adoption of new tests for medically relevant research, including for vitamin D, amino acids, acylcarnitines, immunosuppressants, antidepressants and neuroleptics. These types of studies often lead to validated diagnostic tests, which are used in regulated laboratories.
By combining Chromsystems’ validated reagent kits, calibrators and controls with AB SCIEX mass spectrometers and software, the new solutions enable clinical researchers to broaden the use of mass spectrometry for their research, providing faster and more comprehensive results than alternative technologies, while ensuring compliance with industry standards.
To deliver these solutions in a uniquely integrated, efficient way, Applied Biosystems is expanding its offerings of application-specific iMethod™ Tests, which are pre-configured methods for laboratory use.
New iMethod Tests for clinical researchers are designed to optimize Chromsystems’ specialized chemistries on AB SCIEX triple quadrupole and QTRAP® LC/MS/MS systems. These are supported by an enhanced version of ChemoView™ Software to simplify data interpretation. These systems, software and test methods were developed by the Applied Biosystems/MDS Analytical Technologies joint venture.
Laura Lauman, President of Life Technologies’ Mass Spectrometry Systems Division, “Life Technologies is actively working to help advance clinical research through the expanded use of mass spectrometry technologies. We are responding to the growing demand in this market for more integrated and simplified solutions that enhance medical studies.”
Michael Meier, Managing Director of Chromsystems, “Chromsystems continues to provide clinical laboratories with optimized solutions by developing customized sample preparation and analysis assays. We are redefining how reagents and consumables can add to the precision, reliability and ease of work on a mass spectrometry system. Our agreement with Applied Biosystems is the next step in our efforts to reinforce the confidence that clinical laboratories have in us to work with a leader in mass spectrometry instrument solutions for superior laboratory results.”
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Penn Medicine Biochemist Receives Major Award for Research on Epigenetic Protein Modifications via Mass SpecNews
Benjamin A.Garcia, PhD, an expert in quantitative proteomics and Presidential Professor of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, has been awarded the Biemann Medal by the American Society for Mass Spectrometry (ASMS). The early-career award recognizes significant achievement in basic or applied mass spectrometry.